US Patent Issued to BLOODWORKS on April 14 for "Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipients" (Washington Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,667, issued on April 14, was assigned to BLOODWORKS (Seattle).

"Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipients" was invented by Sherrill J. Slichter (Vashon, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for the prevention or reduction of platelet transfusion associated complications are provided. The subject methods include modifying donor whole blood or platelets prior to transfusion to prevent or reduce alloimmune platelet refractoriness."

The patent was filed on Sept. 28, 2022, under Application No. 17/955,515.

*For furt...